pharmaphorum Podcast

Digitisation of drug R&D: Avoiding new for novelty’s sake

In a new episode of the pharmaphorum podcast, host Nicole Raleigh speaks with Aman Wasan, CEO of ArisGlobal, about the digitisation of drug research and development, including using automation to analyse large datasets to identify new drug development opportunities, with patient safety ever at the forefront of such innovations.

The problems of animal research for human medicine and the alternatives

In today’s podcast, web editor Nicole Raleigh speaks with Dr Pandora Pound, a Fellow at the OCAE and research director at the Safer Medicines Trust, a charity aiming to improve the safety of medicines by facilitating a transition to human biology-based drug development and testing. 

The race to develop innovative products and supply chain solutions

In the final instalment of the five-part, festive series of the pharmaphorum podcast, host Nicole Raleigh speaks with Cencora’s SVP of international commercialisation, Sandra Anderson, and SVP and international managing director of Alloga Europe and ICS, Chris Williams. The topic of discussion centres around considerations and challenges when it comes to launching a biopharmaceutical product in Europe.

The smart-design evolution of the laboratory space

In this penultimate instalment of the five-part, festive series of the pharmaphorum podcast, host Nicole Raleigh speaks with Bobby Savarese, senior principal and business development director at Unispace Life Sciences, exploring how laboratory space requirements have changed since the pandemic.

Investing in the gleams of positivity and hope for life sciences innovation

In this third instalment of the five-part, festive series of the pharmaphorum podcast, web editor Nicole Raleigh speaks with Mark Andrews, investment director of life sciences funds at British Patient Capital (BPC), discussing the vitally hot topic of investment in life sciences.

Looking to the future of UK medical device exports

In this second of our festive podcast series, the pharmaphorum podcast welcomed Brandon Medical CEO Keith Jackson and the Association of British HealthTech Industries (or ABHI) director of communications, Jonathan Evans, to discuss UK medical device exports, including a particular recent strategic APAC partnership and the general and ongoing representation of industry innovation to stakeholders including government, NHS, and regulators.

Exploring the reasons behind increasing burdens on clinical research sites

In the first of a five-part festive instalment of the pharmaphorum podcast, web editor Nicole Raleigh speaks with Advarra’s chief product officer, Elisa Cascade, about the reasons behind increasing burdens on clinical research sites over the last five years.

An investor’s perspective on bio and tech

In today’s episode of the pharmaphorum podcast, host Jonah Comstock sits down for a wide-ranging conversation with Artem Trotsyuk, an investor with LongeVC. His fund focused on therapeutics, diagnostics, and life sciences infrastructure plays.

Why digital therapeutics (DTx) are effective and safe, but not being prescribed

In a new episode of the pharmaphorum podcast, host Nicole Raleigh welcomes Joel Morse, CEO and co-founder of Curavit Clinical Research, and Andy Molnar, CEO of the Digital Therapeutics Alliance (DTA), for a discussion on why it is that digital therapeutics (DTx) are effective and safe, but not being prescribed.

AI drug discovery: Where we are and where we’re going

Today’s guest is founder and CEO of Exscientia, Andrew Hopkins, who has been named a top AI innovator by TIME and was recently appointed a lifetime fellow to both the Royal Society and the Academy of Medical Sciences in the UK.